Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, June 5, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Joseph Pantginis Reiterated (TPST) at Strong Buy and Held Target at $35 on, Jun 5th, 2023
Joseph Pantginis of HC Wainwright & Co., Reiterated "Tempest Therapeutics, Inc." (TPST) at Strong Buy and Held Target at $35 on, Jun 5th, 2023.
Joseph has made no other calls on TPST in the last 4 months.
There are 2 other peers that have a rating on TPST. Out of the 2 peers that are also analyzing TPST, 0 agree with Joseph's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Joseph
- Aydin Huseynov of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $14 on, Friday, April 28th, 2023
- Edward Tenthoff of "Piper Sandler" Maintained at Buy with Decreased Target to $6 on, Thursday, March 23rd, 2023
